Repare Therapeutics Inc.
RPTX
$1.36
$0.118.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -28.67M | -34.41M | -34.77M | 13.16M | -28.03M |
| Total Depreciation and Amortization | 454.00K | 478.00K | 488.00K | 501.00K | 506.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.66M | 4.53M | 5.42M | 5.77M | 5.27M |
| Change in Net Operating Assets | -3.77M | -1.14M | -1.65M | -7.50M | -5.90M |
| Cash from Operations | -27.32M | -30.54M | -30.51M | 11.93M | -28.16M |
| Capital Expenditure | -- | -- | -- | -- | -398.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.59M | 31.08M | 7.12M | -20.32M | 32.28M |
| Cash from Investing | 31.59M | 31.08M | 7.12M | -20.32M | 31.88M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | 166.00K | 0.00 | 375.00K | 105.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.00K | 166.00K | 0.00 | 375.00K | 105.00K |
| Foreign Exchange rate Adjustments | -87.00K | 14.00K | -1.00K | -42.00K | 71.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.18M | 721.00K | -23.40M | -8.05M | 3.90M |